Physician profile
Luis E Linan
NPI 1639266232
$2,042.99
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $216 · 2021: $331 · 2022: $475 · 2023: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $785.98 | 2019-2023 | Saffron |
| Abbvie INC. | $634.20 | 2019-2022 | |
| Therapeuticsmd, INC. | $158.47 | 2019-2021 | |
| Exeltis, USA INC. | $113.52 | 2021-2023 | Slynd |
| Avion Pharmaceuticals | $72.83 | 2019-2022 | |
| Pfizer INC. | $68.32 | 2021-2023 | |
| Allergan, INC. | $52.91 | 2019-2021 | |
| Lilly USA, LLC | $32.76 | 2020-2021 | |
| Hologic Sales and Service, LLC | $28.30 | 2021-2023 | Acessa Provu System |
| Organon LLC | $26.12 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $20.45 | 2019 | |
| Coopersurgical, INC. | $20.22 | 2021 | |
| Galderma Laboratories, L.P. | $15.70 | 2019 | |
| Exact Sciences Corporation | $13.21 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Linan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.